Table 5. Levetiracetam pharmacokinetic parameters from the published literature and from our study.
| Dose | Parameters | Fountain25 | Pellock12 | Chhun18 | Our study |
|---|---|---|---|---|---|
| 10 mg/kg, bid | C12 h (mg/L) | 8.4±3.8 | – | 6.4±2.7 | 11.25±3.10 |
| t1/2 (h) | 4.9±0.6 | – | 6.8±1.5 | 8.13±0.3 | |
| CL/F (mg·kg−1·min−1) | 1.14±0.18 | – | 1.24±0.29 | 0.69±0.1 | |
| 20 mg/kg, bid | C12 h (mg/L) | 15.6±5.3 | – | 12.7±4.7 | 17.5±2.63 |
| t1/2 (h) | 4.9±0.4 | 6.0±1.1 | 6.8±1.5 | 8.13±0.22 | |
| CL/F (mg·kg−1·min−1) | 1.10±0.16 | 1.43±0.36 | 1.24±0.29 | 0.69±0.13 | |
| 30 mg/kg, bid | C12 h (mg/L) | 20.6±5.8 | – | 19.1±7.2 | 31.25±3.8 |
| t1/2 (h) | 4.9±0.7 | – | 6.8±1.5 | 8.13±0.35 | |
| CL/F (mg·kg−1·min−1) | 1.12±0.119 | – | 1.24±0.29 | 0.69±0.09 |
CL/F, apparent oral clearance; t1/2, elimination half-life.